A novel uncovered metal stent (Niti-S Multi-Purpose Type; Taewoong Medical, Seoul,
Korea) designed specifically for multi-stenting in patients with malignant hilar biliary
obstruction recently has been developed. This stent has a small size cell; however,
it is flexible, can expand markedly, and has a 6-F slim delivery system ([Fig. 1 ]). Therefore, the stent makes passing stent cells easier in the stent-in-stent (SIS)
method, while possibly preventing tumor ingrowth better than larger-cell stents. Moreover,
the stent enables simultaneous insertion of two delivery systems, making the stent-by-stent
(SBS) method straightforward [1 ]. Therefore, this novel stent is “multi-purpose,” i. e., it can be suitable for both
SBS and SIS; thus, it can also be particularly useful for the combined SBS and SIS
technique [2 ]
[3 ]
[4 ]
[5 ].
Fig. 1 a, b A novel uncovered metal stent (Niti-S Multi-Purpose Type; Taewoong Medical, Seoul,
Korea) has a small size cell but it is flexible, can expand markedly, which can facilitate
easy passage of the stent cell in the stent-in-stent method and preventing ingrowth
as much as possible. c The stent is mounted on a 6F slim delivery system with an ultra-tapered tip, which
enables the simultaneous stent-by-stent method.
An 88-year-old man developed obstructive jaundice due to extrahepatic cholangiocarcinoma.
Endoscopic retrograde cholangiography revealed severe Bismuth type IIIa stricture,
which extended to the lower bile duct. After two guidewire placements into the right
posterior and left hepatic ducts, two delivery systems of the novel stent were simultaneously
inserted through the stricture. Subsequently, the posterior stent was deployed transpapillary
across the stricture, and a catheter was progressively advanced over the posterior
guidewire. The guidewire was inserted into the right anterior hepatic duct through
the stent cell, and an additional stent was inserted and subsequently deployed in
the SIS method. Finally, the left stent was deployed in the SBS configuration, with
its distal end at the same level as that of the posterior stent ([Fig. 2 ], [Fig. 3 ], [Video 1 ]). The patient’s symptoms improved without the occurrence of adverse events, and
recurrent biliary obstruction was not observed during the follow-up period.
Fig. 2 a After simultaneous delivery of two insertions into the right posterior and left hepatic
ducts, the posterior stent (8 × 120 mm) was deployed. b The posterior guidewire was subsequently advanced to the right anterior hepatic duct
through the stent cell, and an additional metal stent (8 × 80 mm) was inserted and
deployed into the anterior duct using the stent-in-stent method. c, d Finally, the left stent (8 × 120 mm) was deployed in the stent-by-stent configuration
with its distal end at the same level as that of the posterior stent.
Fig. 3 Three-dimensional reconstruction after the combined stent-by-stent and stent-in-stent
deployment.
Video 1 Combined stent-by-stent and stent-in-stent method using a novel multi-purpose metal
stent for a patient with malignant hilar biliary obstruction.
This study described the use of a multipurpose metal stent for malignant hilar biliary
obstruction. This novel stent can serve as a useful option while using any multi-stenting
method.
